| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 11/19/2008 | EP1470107B1 Fluoro substituted cycloalkanoindoles and their use as prostaglandin d2 receptor antagonists |
| 11/19/2008 | EP1441685B1 Compositions for anti-irritating rosacea treatment |
| 11/19/2008 | EP1427326B1 Combination therapy for the treatment of cancer |
| 11/19/2008 | EP1417349B1 Novel molecular target for neurotoxicity |
| 11/19/2008 | EP1372650B1 Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 11/19/2008 | EP1343529B1 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity |
| 11/19/2008 | EP1307226B1 Vitronectin receptor antagonist pharmaceuticals |
| 11/19/2008 | EP1268775B1 The high bone mass gene of 11q13.3 |
| 11/19/2008 | EP0969844B1 Administration of an injectable antibiotic in the ear of an animal |
| 11/19/2008 | CN101310011A Ex-vivo application of solid microparticulate therapeutic agents |
| 11/19/2008 | CN101309705A Preventive or therapeutic agent and method for immune disease |
| 11/19/2008 | CN101309682A Modulation of neurogenesis by pde inhibition |
| 11/19/2008 | CN101309679A 胶冻组合物 Jelly composition |
| 11/19/2008 | CN101305992A Compound sustained-released injection containing neonatal blood vessel restraining agent |
| 11/19/2008 | CN101305991A Compound sustained-released injection containing neonatal blood vessel restraining agent |
| 11/19/2008 | CN101305982A 局部凝胶给药体系 Topical gel delivery system |
| 11/19/2008 | CN100434120C Amphipathic fluorescence target nano micelle and its preparation method |
| 11/19/2008 | CN100434079C Novel virus proliferaton inhibition/virucidal method and novel pyradine nucleotide/pyradine nucleoside analogue |
| 11/18/2008 | US7452982 An immunogenic complex characterised in that an enzyme is integrated into an immunostimulating complex (ISCOM) containing a glycoside, a lipid and an antigen |
| 11/18/2008 | US7452977 Antibody to a kinase capable of site-specific phosphorylation of IκBα |
| 11/18/2008 | US7452916 Administering arginine, lysine; cardiovascular disorder therapy |
| 11/18/2008 | US7452907 Conformationally constrained analogs useful as antidiabetic and antiobesity agents and method |
| 11/18/2008 | US7452904 1-alkyl-1-azoniabicyclo' 2.2.2 octane carbamate derivatives and their use as muscarinic receptor antagonists |
| 11/18/2008 | US7452894 Purine derivatives as purinergic receptor antagonists |
| 11/18/2008 | US7452891 MCH antagonists and their use in the treatment of obesity |
| 11/18/2008 | US7452877 Irritable bowel disorders; controlling permeability of intestine tissue ; anticholinergic agent |
| 11/18/2008 | US7452874 Thrombopoietin mimetics |
| 11/18/2008 | US7452871 Compositions and methods for treating mammals with modified alginates and modified pectins |
| 11/18/2008 | US7452858 Administering exendin, or an antagonist thereof; reducing blood glucose concentration |
| 11/18/2008 | US7452723 Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders |
| 11/18/2008 | US7452717 Carboxylesterase; antitumor agents; drug screening; bioassay |
| 11/18/2008 | US7452556 Compositions for the treatment of pilosebaceous gland inflammations comprising aluminum fluoride |
| 11/18/2008 | US7452544 Bacteriocins and novel bacterial strains |
| 11/18/2008 | US7452533 Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol |
| 11/18/2008 | US7452532 Transluminal application of adult stem cells for body organ tissue repair |
| 11/18/2008 | US7452531 Compositions and methods for tumor-targeted delivery of effector molecules |
| 11/18/2008 | US7452530 Administering a blocking agent of tumor necrosis factors or receptors; treatment of Sin Nombre (SNV), Ebola, Marburg, Lassa, and Dengue viral disease |
| 11/18/2008 | CA2469369C Compositions containing both sedative and non-sedative antihistamines |
| 11/18/2008 | CA2434682C Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 11/18/2008 | CA2422379C Pyrazole compounds useful as protein kinase inhibitors |
| 11/18/2008 | CA2413163C 3'-prodrugs of 2'-deoxy-.beta.-l-nucleosides |
| 11/18/2008 | CA2406846C Pharmacotherapeutic process and composition for central nervous system disorders |
| 11/18/2008 | CA2395481C Hormone receptor modulation |
| 11/18/2008 | CA2383222C Optically active isomers of ketotifen and therapeutically active metabolites thereof |
| 11/18/2008 | CA2376202C Novel preparation and administration form comprising an acid-labile active compound |
| 11/18/2008 | CA2362281C Combinations for the treatment of diseases involving angiogenesis |
| 11/18/2008 | CA2343116C Methods and compositions for increasing intestinal absorption of fats |
| 11/18/2008 | CA2340417C Methods for forming regional tissue adherent barriers and drug delivery systems |
| 11/18/2008 | CA2335686C Particulate acellular tissue matrix |
| 11/18/2008 | CA2333442C Spray composition |
| 11/18/2008 | CA2329167C Method and apparatus for enhancing flux rates of a fluid in a microporated biological tissue |
| 11/18/2008 | CA2316298C Fat blend |
| 11/18/2008 | CA2314326C Transdermal therapeutic device and method with capsaicin and capsaicin analogs |
| 11/18/2008 | CA2301899C Agent with an antidepressant activity |
| 11/18/2008 | CA2264941C Use of a combination of an atypical antipsychotic and a serotonin reuptake inhibitor for treatment of psychosis |
| 11/18/2008 | CA2245125C Use of one extract of at least one rosaceae plant |
| 11/18/2008 | CA2205112C Method and composition for treating mammalian diseases caused by inflammatory response |
| 11/18/2008 | CA2107884C Use of vasoactive intestinal peptide (vip) to induce temporary paralysis of the gastrointestinal tract |
| 11/18/2008 | CA1341584C Method of amplifying and detecting nucleic acid sequences |
| 11/13/2008 | WO2008137787A2 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 11/13/2008 | WO2008137571A1 Methods of treating neurodegenerative diseases |
| 11/13/2008 | WO2008137444A1 N-halogenated amino acid formulations with anti-inflammatory compounds |
| 11/13/2008 | WO2008137126A2 Combination therapy for the treatment of hcv infection |
| 11/13/2008 | WO2008136519A1 Cytotoxic t cell activator comprising ep4 agonist |
| 11/13/2008 | WO2008136511A1 Therapeutic agent for diabetic neuropathy |
| 11/13/2008 | WO2008136377A1 Bicyclic heterocyclic compound |
| 11/13/2008 | WO2008136213A1 Radiosensitivity-enhancing agent |
| 11/13/2008 | WO2008135855A2 Nanoparticles comprising a cholesteryl ester transfer protein inhibitor and a nonionizable polymer |
| 11/13/2008 | WO2008135548A1 Use of a naphtoic acid derivative in combination with red and/or blue light for treating acne vulgaris |
| 11/13/2008 | WO2008135085A1 Synergistic active preparations comprising 1,2-decanediol and further antimicrobial active compounds |
| 11/13/2008 | WO2008092103A9 Combination cancer treatments comprising elsamitrucin and other agents |
| 11/13/2008 | WO2008036846A3 Combination comprising an hmg-coa reductase inhibitor and a second neurogenic agent for treating a nervous system disorder and increasing neurogenesis |
| 11/13/2008 | US20080281236 Devices and methodologies useful in body aesthetics |
| 11/13/2008 | US20080281092 Novel diphenylazetidinones, process for their preparation, medicaments comprising these compounds and their use |
| 11/13/2008 | US20080280939 Combination of Organic Compounds |
| 11/13/2008 | US20080280863 Concurrent administering by mouth a corticosteroid and tricyclic antidepressant compound; immunoinflamamtory disorders; antiarthritic agents; skin disorders; inflammatory bowel disorders; Crohn's disorders; autoimmune disease; asthma; multiple sclerosis; diabetes; lupus |
| 11/13/2008 | US20080280840 Meloxicam for the treatment of respiratory diseases in pigs |
| 11/13/2008 | US20080280354 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 11/13/2008 | US20080279949 Such as paclitaxel and stabilizer |
| 11/13/2008 | US20080279887 Recombinant virus encoding an antigen of a disease state; second recombinant virus encoding an immunostimulatory molecule with an exogenous immunostimulatory molecule, chemotherapeutic drug, antibiotic, antiviral drug or antifungal drug. |
| 11/13/2008 | US20080279862 Using interleukin-1 specfic immunoglobulin fusion and tumor necrosis factor inhibitors to treat inflammatory and/or autoimmune disorders |
| 11/13/2008 | US20080279860 Using endothelial growth factor specific monoclonal antibody for treatment and prevention of metastatic ovarian cancer; immunotherapy |
| 11/13/2008 | US20080279843 Using concentration of inflammation marker protein as evaluative signal for enzyme inhibitor dispension; drug delivery and antidiabetic agents |
| 11/13/2008 | US20080279813 Using interferon and interleukin receptor expression profiles as evaluative tools in diagnosis of cancer, autoimmune, allergic, transplant rejection and infectious disorders |
| 11/13/2008 | DE19830732B4 Zusammensetzung, enthaltend mindestens einen die Blutfettwerte beeinflussenden Wirkstoff und seine Verwendung A composition comprising at least one lipid levels influencing drug and its use |
| 11/13/2008 | DE10362194B4 Verfahren zum Testen der Aktivität einer möglichen wirksamen Substanz, die die enzymatische Aktivität der Phospholipase A2 hemmen kann A method for testing the activity of a possible active substance which inhibit the enzymatic activity of phospholipase A2 can |
| 11/13/2008 | CA2686051A1 Combination therapy for the treatment of hcv infection |
| 11/13/2008 | CA2684922A1 Cytotoxic t cell activator comprising ep4 agonist |
| 11/13/2008 | CA2684722A1 Combination therapy with a compound acting as a platelet adp receptor inhibitor |
| 11/13/2008 | CA2684186A1 N-halogenated amino acid formulations with anti-inflammatory compounds |
| 11/13/2008 | CA2684091A1 Use of a naphtoic acid derivative in combination with red and/or blue light for treating acne vulgaris |
| 11/12/2008 | EP1990427A1 Npy y4 agonist as therapeutic agent for disease accompanied by intestinal tract dysfunction |
| 11/12/2008 | EP1990060A1 Remedy for disease associated with choroidal angiogenesis |
| 11/12/2008 | EP1990051A1 Combinations of SSRI and estrogenic agents |
| 11/12/2008 | EP1990046A1 Condensation aerosol containing loxapine or prochlorperazine for inhalation |
| 11/12/2008 | EP1990040A1 Nanoparticle delivery vehicle |
| 11/12/2008 | EP1988972A2 Proteasom or ups inhibitor for treating infections with influenza viruses |
| 11/12/2008 | EP1988927A2 Engineered antibody-stress protein fusions |
| 11/12/2008 | EP1988923A1 Methods for treating unwanted weight loss or eating disorders by administering a trkb agonist |
| 11/12/2008 | EP1988898A2 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin |